Literature DB >> 22681045

Neurosarcoidosis-related intracranial haemorrhage: three new cases and a systematic review of the literature.

J P O'Dwyer1, B A Al-Moyeed, M A Farrell, C N Pidgeon, D R Collins, A Fahy, J Gibney, N Swan, O J Dempsey, D P Kidd, J M Reid, S Smyth, D J H McCabe.   

Abstract

BACKGROUND AND
PURPOSE: Intracranial haemorrhage in neurosarcoidosis (NS-ICH) is rare, poorly understood and the diagnosis of NS may not be immediately apparent.
METHODS: The clinical features of three new NS-ICH cases are described including new neuropathological findings and collated with cases from a systematic literature review. CASES: (i) A 41-year-old man with headaches, hypoandrogenism and encephalopathy developed a cerebellar haemorrhage. He had neuropathological confirmation of NS with biopsy-proven angiocentric granulomata and venous disruption. He responded to immunosuppressive therapy. (ii) A 41-year-old man with no history of hypertension was found unconscious. A subsequently fatal pontine haemorrhage was diagnosed. Liver biopsy revealed sarcoid granulomas. (iii) A 36-year-old man with raised intracranial pressure headaches presented with a seizure and a frontal haemorrhage. Hilar lymph node biopsy confirmed sarcoidosis, and he was treated successfully. Systematic review: Twelve other published cases were identified and collated with our cases. Average age was 36 years and M:F = 2.3:1; 46% presented with neurological symptoms and 31% had CNS-isolated disease. Immediate symptoms of ICH were acute/worsening headache or seizures (60%). ICH was supratentorial (62%), infratentorial (31%) or subarachnoid (7%). Forty percent had definite NS, 53% probable NS and 7% possible NS (Zajicek criteria). Antigranulomatous/immunosuppressive therapy regimens varied and 31% died.
CONCLUSIONS: This series expands our knowledge of the pathology of NS-ICH, which may be of arterial or venous origin. One-third have isolated NS. Clinicians should consider NS in young-onset ICH because early aggressive antigranulomatous therapy may improve outcome.
© 2012 The Author(s) European Journal of Neurology © 2012 EFNS.

Entities:  

Mesh:

Year:  2012        PMID: 22681045     DOI: 10.1111/j.1468-1331.2012.03783.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  10 in total

Review 1.  Cerebrovascular Manifestations of Neurosarcoidosis: An Underrecognized Aspect of the Imaging Spectrum.

Authors:  G Bathla; P Watal; S Gupta; P Nagpal; S Mohan; T Moritani
Journal:  AJNR Am J Neuroradiol       Date:  2017-12-28       Impact factor: 3.825

2.  Neurosarcoidosis: clinical presentations and changing treatment patterns in an Irish Caucasian population.

Authors:  K O'Connell; L Williams; J Jones; D J H McCabe; D Murphy; R Killeen; N Tubridy; S O'Riordan; C McGuigan
Journal:  Ir J Med Sci       Date:  2017-01-18       Impact factor: 1.568

3.  A Case of Neurosarcoid Presenting as Multiple Intraparenchymal Hemorrhages.

Authors:  Amit Mehta; Fahad Khan; Chris Wagner; Taymour Hashemzadeh; Andrew Stemer; Emily A Sloan; Douglas Mayson; Faria Amjad
Journal:  Neurohospitalist       Date:  2021-06-30

Review 4.  Neurosarcoidosis: a clinical approach to diagnosis and management.

Authors:  Richard T Ibitoye; A Wilkins; N J Scolding
Journal:  J Neurol       Date:  2016-11-22       Impact factor: 4.849

5.  Acute central nervous system vasculitis as a manifestation of neurosarcoidosis: A case report and literature review.

Authors:  Toyonobu Maekawa; Yukihiro Goto; Takuma Aoki; Akihiko Hino; Hideki Oka; Shigeomi Yokoya; Akihiro Fujii
Journal:  Radiol Case Rep       Date:  2020-12-14

6.  Clinical characterization and outcomes of 85 patients with neurosarcoidosis.

Authors:  Manuel Ramos-Casals; Roberto Pérez-Alvarez; Belchin Kostov; Ricardo Gómez-de-la-Torre; Carlos Feijoo-Massó; Joel Chara-Cervantes; Blanca Pinilla; Andrés González-García; José-Salvador Garcia-Morillo; Miguel López-Dupla; Begoña De-Escalante; Javier Rascón; Patricia Perez-Guerrero; Mariona Bonet; Gracia Cruz-Caparrós; Ana Alguacil; José-Luis Callejas; Eva Calvo; Cristina Soler; Angel Robles; Borja de Miguel-Campo; Pedro Oliva-Nacarino; Jorge Estela-Herrero; Lucio Pallarés; Pilar Brito-Zerón; Yolanda Blanco
Journal:  Sci Rep       Date:  2021-07-02       Impact factor: 4.379

7.  Spinal cord hemorrhage in a patient with neurosarcoidosis on long-term corticosteroid therapy: case report.

Authors:  Benoit Pegat; Sophie Drapier; Xavier Morandi; Gilles Edan
Journal:  BMC Neurol       Date:  2015-07-30       Impact factor: 2.474

8.  Systemic Sarcoidosis Presenting with Headache and Stroke-Like Episodes.

Authors:  J Campbell; R Kee; D Bhattacharya; P Flynn; M McCarron; A Fulton
Journal:  Case Reports Immunol       Date:  2015-09-29

9.  Isolated spinal neurosarcoidosis: An enigmatic intramedullary spinal cord pathology-case report and review of the literature.

Authors:  Manish K Kasliwal; Aparna Harbhajanka; Sukriti Nag; John E O'Toole
Journal:  J Craniovertebr Junction Spine       Date:  2013-07

10.  Vascular Involvement in Neurosarcoidosis: Early Experiences From Intracranial Vessel Wall Imaging.

Authors:  Girish Bathla; Lama Abdel-Wahed; Amit Agarwal; Tracey A Cho; Sarika Gupta; Karra A Jones; Sarv Priya; Neetu Soni; Bruce A Wasserman
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2021-08-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.